Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bicalutamide + LHRH-A vs. flutamide + LHRH-A for metastatic prostate cancer

Oct. 29, 1997

Banyu discloses protein farnesyltransferase inhibitors

Oct. 29, 1997

Biomeasure discloses protein farnesyltranserase inhibitors

Oct. 29, 1997

Antitumor effects of Techniclone's LYM-2 reported

Oct. 29, 1997

Research team identifies effector of morphological changes during apoptosis

Oct. 28, 1997

Oxford BioMedica acquires novel anticancer technology

Oct. 28, 1997

Endorex raises funds for clinical testing of antitumor drugs

Oct. 28, 1997

Preclinical studies on FK-317 presented at cancer meeting

Oct. 28, 1997

DAB-720: a new EGF receptor TK inhibitor from Mitsubishi Chemical

Oct. 28, 1997

Mechanism of action and in vivo antitumor efficacy reported for CS-682

Oct. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...